1. Home
  2. CULP vs IVVD Comparison

CULP vs IVVD Comparison

Compare CULP & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.75

Market Cap

52.7M

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.40

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
IVVD
Founded
1972
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
692.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CULP
IVVD
Price
$3.75
$2.40
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.33
AVG Volume (30 Days)
37.7K
12.4M
Earning Date
12-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,919,000.00
$50,039,000.00
Revenue This Year
$1.93
$103.88
Revenue Next Year
$2.77
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
332.71
52 Week Low
$3.42
$0.35
52 Week High
$5.94
$3.07

Technical Indicators

Market Signals
Indicator
CULP
IVVD
Relative Strength Index (RSI) 40.17 55.98
Support Level $3.78 $2.15
Resistance Level $4.04 $2.59
Average True Range (ATR) 0.16 0.18
MACD 0.00 -0.01
Stochastic Oscillator 22.81 59.80

Price Performance

Historical Comparison
CULP
IVVD

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: